MPHOSPH10, M-phase phosphoprotein 10, 10199

N. diseases: 6; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003578
Disease: Apnea
Apnea
0.010 Biomarker phenotype BEFREE Other parameters from PSG or overnight oximetry such as ODI, CT90, mean and minimal Spo<sub>2</sub>, and longest apnea duration can be associated with postoperative complications and may provide additional value in risk stratification and minimization. 30359618 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE In the entire population and in subjects with T2DM, the multivariate regression analysis showed a direct interaction between the nocturnal concentration of urine metanephrines and the CT90. 31736881 2019
CUI: C0034067
Disease: Pulmonary Emphysema
Pulmonary Emphysema
0.010 Biomarker disease BEFREE Patients with moderate/severe emphysema and greater CT90 presented a worse result on 6MWT. 30100206 2019
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.010 Biomarker disease BEFREE The results indicate that liposomal CT90-BikDD is an effective systemic breast cancer-targeting gene therapy. 16514421 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE Expression of BikDD was readily detectable in the tumors but not in the normal organs (such as heart) of CT90-BikDD-treated animals. 16514421 2006
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.010 Biomarker disease BEFREE The results indicate that liposomal CT90-BikDD is an effective systemic breast cancer-targeting gene therapy. 16514421 2006